
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10911717
[patent_doc_number] => 20140314734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR SPECIFIC REGULATION OF PYRUVATE DEHYDROGENASE KINASE'
[patent_app_type] => utility
[patent_app_number] => 14/238449
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12831
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238449 | Compositions and methods for specific regulation of pyruvate dehydrogenase kinase | Aug 9, 2012 | Issued |
Array
(
[id] => 9546719
[patent_doc_number] => 20140171368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'POLYANION NANOCOMPLEXES FOR THERAPEUTIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/237445
[patent_app_country] => US
[patent_app_date] => 2012-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5749
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237445
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237445 | Polyanion nanocomplexes for therapeutic applications | Aug 6, 2012 | Issued |
Array
(
[id] => 9659076
[patent_doc_number] => 20140230081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/237880
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19435
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237880
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237880 | POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS | Aug 5, 2012 | Abandoned |
Array
(
[id] => 10649391
[patent_doc_number] => 09365627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Endomucin as an anti-inflammatory agent'
[patent_app_type] => utility
[patent_app_number] => 14/237082
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 40
[patent_no_of_words] => 8516
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237082 | Endomucin as an anti-inflammatory agent | Aug 5, 2012 | Issued |
Array
(
[id] => 12144806
[patent_doc_number] => 09879049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-30
[patent_title] => 'Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains'
[patent_app_type] => utility
[patent_app_number] => 14/236876
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16618
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236876
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236876 | Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains | Aug 2, 2012 | Issued |
Array
(
[id] => 11430172
[patent_doc_number] => 09568485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation'
[patent_app_type] => utility
[patent_app_number] => 14/233601
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8217
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233601
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233601 | Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation | Jul 19, 2012 | Issued |
Array
(
[id] => 10906146
[patent_doc_number] => 20140309158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOMODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/233114
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28095
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233114 | Compositions and methods for immunomodulation | Jul 15, 2012 | Issued |
Array
(
[id] => 11388733
[patent_doc_number] => 09549964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Diagnosis, prognosis, and treatment of kidney disease'
[patent_app_type] => utility
[patent_app_number] => 14/131866
[patent_app_country] => US
[patent_app_date] => 2012-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 16090
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131866
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131866 | Diagnosis, prognosis, and treatment of kidney disease | Jul 12, 2012 | Issued |
Array
(
[id] => 10614871
[patent_doc_number] => 09334306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Leukemia stem cell targeting ligands and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/130909
[patent_app_country] => US
[patent_app_date] => 2012-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21861
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130909
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130909 | Leukemia stem cell targeting ligands and methods of use | Jul 8, 2012 | Issued |
Array
(
[id] => 11773466
[patent_doc_number] => 09382304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Engineered polypeptides having enhanced duration of action with reduced immunogenicity'
[patent_app_type] => utility
[patent_app_number] => 14/129815
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 27
[patent_no_of_words] => 49663
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129815
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129815 | Engineered polypeptides having enhanced duration of action with reduced immunogenicity | Jul 2, 2012 | Issued |
Array
(
[id] => 10008054
[patent_doc_number] => 09051562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 14/126253
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10277
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126253 | Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer | Jun 14, 2012 | Issued |
Array
(
[id] => 11794120
[patent_doc_number] => 09403870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Methods of phosvitin extraction and phosphopeptide preparation from egg yolk'
[patent_app_type] => utility
[patent_app_number] => 14/123890
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 11164
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123890 | Methods of phosvitin extraction and phosphopeptide preparation from egg yolk | Jun 10, 2012 | Issued |
Array
(
[id] => 10649390
[patent_doc_number] => 09365626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Simukunin'
[patent_app_type] => utility
[patent_app_number] => 14/122300
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 18783
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122300 | Simukunin | May 24, 2012 | Issued |
Array
(
[id] => 9785163
[patent_doc_number] => 20140301983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/119341
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21992
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119341
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/119341 | Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use | May 23, 2012 | Issued |
Array
(
[id] => 10600150
[patent_doc_number] => 09320698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-26
[patent_title] => 'Peptide tyrosinase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/117012
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 17872
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117012
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117012 | Peptide tyrosinase inhibitors and uses thereof | May 9, 2012 | Issued |
Array
(
[id] => 9510985
[patent_doc_number] => 20140147476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'ORGANIC NANOTUBE HAVING HYDROPHOBIZED INNER SURFACE, AND ENCAPSULATED MEDICINAL AGENT PREPARED USING THE NANOTUBE'
[patent_app_type] => utility
[patent_app_number] => 14/116182
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22512
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116182
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116182 | Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube | Mar 29, 2012 | Issued |
Array
(
[id] => 8417602
[patent_doc_number] => 20120245101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'SYNTHETIC APOLIPOPROTEIN E MIMICKING POLYPEPTIDES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/429022
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 46933
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/429022 | SYNTHETIC APOLIPOPROTEIN E MIMICKING POLYPEPTIDES AND METHODS OF USE | Mar 22, 2012 | Abandoned |
Array
(
[id] => 10141132
[patent_doc_number] => 09173919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Collagen-targeted nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 14/000036
[patent_app_country] => US
[patent_app_date] => 2012-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11307
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000036 | Collagen-targeted nanoparticles | Feb 15, 2012 | Issued |
Array
(
[id] => 10422543
[patent_doc_number] => 20150307554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'NTS-POLYPLEX NANOPARTICLES SYSTEM FOR GENE THERAPY OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/984548
[patent_app_country] => US
[patent_app_date] => 2012-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12023
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984548 | NTS-POLYPLEX NANOPARTICLES SYSTEM FOR GENE THERAPY OF CANCER | Feb 9, 2012 | Abandoned |
Array
(
[id] => 8301936
[patent_doc_number] => 20120184491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Methods and Compound to Inhibit Ca2+ Permeable Cation Conductance'
[patent_app_type] => utility
[patent_app_number] => 13/351611
[patent_app_country] => US
[patent_app_date] => 2012-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9885
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351611
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/351611 | Methods and compound to inhibit Ca2+ permeable cation conductance | Jan 16, 2012 | Issued |